FDA Approves Zoryve for Atopic Dermatitis
The once-daily, nonsteroidal cream is approved for adults and children 6 years and older
Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in Acne
Reduction seen in inflammatory and noninflammatory lesions, improvement seen in overall quality of life with EPA/DHA
Rural Residents Continue to Have Higher Odds of Skin Cancer
Rural-urban differences magnified by lower income and race
Postpandemic Physician Revenue Recovery Varies by Specialty, Practice Type
Pathology, psychiatry revenue experienced robust recovery by 2022; surgery, oncology revenue remained at or below baseline
Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue
Increasing joint pain intensity associated with overall fatigue in patients with psoriasis with or without psoriatic arthritis
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
Recurrence developed in more patients who did not receive additional treatment and in fewer receiving nonsurgical treatments
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus
Decrease in Peak Pruritus Numeric Rating Scale for PN, chronic pruritus of unknown origin patients
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
Consistent survival benefit seen across several prespecified subgroups, including those with a BRAF V600E mutation
2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 Months
Decrease seen across sociodemographic and geographic characteristics, including sex, family income, education, region, urbanization level
Approximately 7 Percent of U.S. Population Uninsured in 2023
10.9 percent of adults aged 18 to 64 years were uninsured at the time of interview in 2023, as were 3.9 percent of children aged 0 to 17 years
